CorTec receives second FDA ‘Breakthrough Device’ designation for its brain computer interface


CorTec has obtained a second US Meals and Drug Administration Breakthrough Gadget Designation for its Mind Interchange brain-computer interface, this time protecting communication for individuals with non-progressive quadriplegia.

The designation covers using the implantable BCI to allow individuals with paralysis in all 4 limbs to manage a pc cursor by means of neural indicators, offering an unbiased technique of interacting with computer systems and different digital techniques.

The Freiburg, Germany-based neurotechnology firm obtained its first Breakthrough Gadget Designation for Mind Interchange in April 2026 for stroke motor rehabilitation.

The FDA grants Breakthrough Gadget Designation to applied sciences which have the potential to supply simpler therapy or analysis of life-threatening or irreversibly debilitating circumstances. This system gives a prioritized and extra interactive regulatory overview course of throughout machine growth.

CorTec says the 2 designations show the potential for a similar Mind Interchange platform to function each as a therapeutic and an assistive BCI.


For stroke rehabilitation, the system delivers focused mind stimulation meant to help motor restoration. For communication functions, it data and decodes neural indicators related to a person’s intentions and interprets them into digital instructions.

The corporate says a participant in its ongoing stroke examine on the College of Washington has already demonstrated laptop management by means of thought utilizing the identical implant. The brand new communication program will examine this functionality beneath structured FDA engagement.

Non-progressive quadriplegia, which might consequence from spinal wire harm, can depart cognitive operate intact whereas inflicting lasting loss or impairment of voluntary motion in all 4 limbs.

CorTec is creating Mind Interchange to permit individuals with these circumstances to manage a pc cursor immediately by means of neural exercise, doubtlessly offering unbiased entry to digital gadgets utilized in on a regular basis life.

Bidirectional brain-computer interface

Mind Interchange is a totally implantable, wi-fi and battery-free BCI designed to report cortical indicators and translate them into digital instructions in actual time.

The system is bidirectional and closed-loop, which means it could each report neural exercise and ship focused electrical stimulation.

CorTec says the identical {hardware} structure can subsequently help each of its FDA-designated functions – decoding motion intention for communication and offering cortical stimulation meant to help motor restoration following stroke.

Dr Frank Desiere, CEO of CorTec, says: “This second designation confirms the platform technique behind Mind Interchange.

“To our information, solely a handful of BCI corporations worldwide, amongst them Neuralink and Paradromics, maintain multiple FDA Breakthrough Gadget Designation, and no different system is designated for stroke motor rehabilitation. We constructed one implantable system to combat a number of neurological circumstances, and the FDA has now acknowledged its breakthrough potential in two of them. Our job now’s to show that recognition into authorized therapies that attain sufferers.”

Mara Assis, head of regulatory affairs and high quality administration at CorTec, says: “Designing Mind Interchange as an indication-agnostic platform from day one is precisely why it was doable to maneuver so shortly by means of this course of.

“The platform rests on greater than a decade of constructing mind interfaces — over 50 of our electrodes have been implanted in people — and that progress is what carries a designation from paper right into a medical program.”

Stroke rehabilitation stays lead program

Stroke motor rehabilitation stays CorTec’s lead medical program.

Mind Interchange is at the moment being evaluated in an FDA-approved Investigational Gadget Exemption examine on the College of Washington in Seattle, the place three sufferers have been implanted so far.

CorTec says the system has demonstrated greater than 500 days of steady sign stability, with the outcomes revealed in Scientific Information, a peer-reviewed journal from Nature Portfolio.

The platform can also be being evaluated in a registered epilepsy examine at Mayo Clinic, which has enrolled 13 sufferers so far.

A communication examine involving individuals with paralysis, often called INTENSE, can also be deliberate at UMC Utrecht, whereas CorTec says it’s creating the expertise for additional potential indications, together with melancholy.

The corporate can also be enrolled within the FDA’s Complete Product Life Cycle Advisory Program, or TAP, for its stroke program.

Mind Interchange makes use of non-penetrating cortical floor electrodes, which means its electrodes are positioned on the floor relatively than getting into mind tissue.

Greater than 50 CorTec cortical electrodes have been implanted in people throughout greater than a decade of growth, in accordance with the corporate.

Based in Freiburg in 2010, CorTec is creating Mind Interchange as a platform that may doubtlessly be tailored to a number of neurological circumstances relatively than creating separate implantable techniques for particular person indications.

The corporate additionally operates a contract growth and manufacturing enterprise supplying lively implantable applied sciences to different corporations within the neurotechnology sector.